[
    {
        "molecule_name": "CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=0.3",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.3",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-101, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=0.2",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-101, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.2",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=9",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-9",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=8",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-8",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=7",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-7",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=6",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-6",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=4",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-4",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=3",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-103, CNG-CD19-110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD19-107, CNG-CD19-108, CNG-CD19-109",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-3",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG- CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD19-102, CNG-CD19-103, CNG-CD19-104, CNG- CD19-105, CNG-CD 19- 106, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.3 nM or in the range of 0.1-0.3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 101, CNG-CD 19- 103, CNG-CD19-104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD 19- 109 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-101, CNG-CD 19- 103, CNG-CD 19- 104, CNG-CD19-105, CNG-CD19-107, CNG-CD19-108, or CNG-CD19-109 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.2 nM or in the range of 0.1-0.2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19- 103, CNG-CD 19- 110, CNG-CD 19- 104, CNG-CD 19- 105, CNG-CD 19- 106, CNG-CD 19- 107, CNG- CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG- CD19-103, CNG-CD 19- 110, CNG-CD19-104, CNG-CD19-105, CNG-CD19-106, CNG-CD 19- 107, CNG-CD 19- 108, or CNG-CD 19- 109 binds cynomolgus CD 19 with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤2 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤1 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤0.5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-2 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-1 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤0.4 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤0.3 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤0.2 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤0.1 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.4 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.3 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.2 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "human CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "0.05-0.1 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "cynomolgus CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤8 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "cynomolgus CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤7 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "cynomolgus CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤6 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "cynomolgus CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "cynomolgus CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤4 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710",
        "protein_target_name": "cynomolgus CD 19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤3 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-8 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-7 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-6 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-4 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710",
        "protein_target_name": "cynomolgus CD19",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-3 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD lower than or equal to 2 nM, 1 nM, or 0.5 nM, as measured by surface plasmon resonance (SPR) when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD 19 or an extracellular fragment thereof with a KD in the range of 0.05-2 nM, in the range of 0.05-1 nM, or in the range of 0.05-0.5 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD lower than or equal to 0.4 nM, 0.3 nM, 0.2 nM, or 0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD 19-701, CNG-CD 19-706, CNG-CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds human CD19 or an extracellular fragment thereof with a KD in the range of 0.05-0.4 nM, 0.05- 0.3 nM, 0.05-0.2 nM, or 0.05-0.1 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site derived from CNG-CD19-701, CNG-CD 19-702, CNG-CD19-703, CNG-CD19-704, CNG-CD19-705, CNG-CD19-706, CNG- CD 19-707, CNG-CD 19-708, CNG-CD 19-709, or CNG-CD 19-710 binds cynomolgus CD 19 with a KD lower than or equal to 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigenbinding site derived from CNG-CD 19-701, CNG-CD 19-702, CNG-CD 19-703, CNG-CD 19-704, CNG-CD19-705, CNG-CD19-706, CNG-CD19-707, CNG-CD19-708, CNG-CD19-709, or CNG-CD19-710 binds cynomolgus CD19 with a KD in the range of 1-8 nM, 1-7 nM, 1-6 nM, 1- 5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤2.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-2.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤2.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "antigen-binding site",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-2.5",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\nIn certain embodiments, the antigen-binding site binds human serum albumin with a KD in the range of 1- 10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=10 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-10 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120",
        "protein_target_name": "cynomolgus serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=9 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120",
        "protein_target_name": "cynomolgus serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-9 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120",
        "protein_target_name": "mouse serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=100 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120",
        "protein_target_name": "mouse serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-100 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=10 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117",
        "protein_target_name": "human serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-10 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=2.5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-2.5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "<=2.5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117",
        "protein_target_name": "protein A",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "1-2.5 nM",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD lower than or equal to 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds cynomolgus serum albumin with a KD in the range of 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD lower than or equal to 100 nM, 90 nM, 80 nM, 70 nM, 60 nM, 50 nM, 40 nM, 30 nM, 20 nM, or 10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-103, CNG-HSA-104, CNG-HSA-108, CNG-HSA-109, CNG-HSA-110, CNG-HSA-111, CNG-HSA-112, CNG-HSA-115, CNG-HSA-116, CNG-HSA-117, CNG-HSA-118, CNG-HSA-119, or CNG-HSA-120 binds mouse serum albumin with a KD in the range of 1-100 nM, 1-90 nM, 1-80 nM, 1-70 nM, 1-60 nM, 1-50 nM, 1-40 nM, 1-30 nM, 1-20 nM, or 1-10 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD lower than or equal to 10 nM, 9 nM, 8 nM, 7 nM, 6 nM, 5 nM, 4 nM, or 3 nM and binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-113, CNG-HSA-116, or CNG-HSA-117 binds human serum albumin with a KD in the range of 1-10 nM, 1-9 nM, 1-8 nM, 1-7 nM, 1-6 nM, 1-5 nM, 1-4 nM, or 1-3 nM and binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD lower than or equal to 2.5 nM or 2 nM, as measured by SPR when the antigen-binding site is present as a monomer.\n\nIn certain embodiments, the antigen-binding site derived from CNG-HSA-101, CNG-HSA-102, CNG-HSA-104, CNG-HSA-109, CNG-HSA-116, or CNG-HSA-117 binds protein A with a KD in the range of 1-2.5 nM or 1-2 nM, as measured by SPR when the antigen-binding site is present as a monomer."
    },
    {
        "molecule_name": "CNG-HSA-101, CNG-HSA-103, CNG-HSA-106, CNG-HSA-107, CNG-HSA-108, CNG-HSA-109, CNG-HSA-111, CNG-HSA-113, CNG-HSA-114, CNG-HSA-115, CNG-HSA-116, CNG-HSA-118, CNG-HSA-120",
        "protein_target_name": "mouse serum albumin",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "< 4-fold higher than the KD with which the same antibody bound human serum albumin",
        "unit": null,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe sensors with loaded HCAbs were exposed to 100 nM human serum albumin for 3 minutes, and subsequently transferred to assay buffer for 3 minutes for off-rate measurement.\nCNG-HSA-101, CNG-HSA-103, CNG-HSA-106, CNG-HSA-107, CNG-HSA-108, CNG-HSA-109, CNG-HSA-111, CNG-HSA-113, CNG-HSA-114, CNG-HSA-115, CNG-HSA-116, CNG-HSA-118, and CNG-HSA-120 bound mouse serum albumin with a KD value less than 4-fold higher than the KD with which the same antibody bound human serum albumin."
    }
]